unknown
Stage
1
Investors
About
Congenica provides a clinical-grade genomic interpretation platform that analyzes DNA sequencing data to help clinicians and diagnostic labs prioritize and interpret genetic variants. Its software delivers variant annotation, phenotype-driven filtering, and generates reports to support clinical decision-making.
Explore Congenica's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.